FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,018 | -11.8% | 9,057 | +3.7% | 0.00% | – |
| Q2 2023 | $77,130 | -2.4% | 8,735 | -31.1% | 0.00% | – |
| Q1 2021 | $79,000 | -16.0% | 12,685 | +0.3% | 0.00% | – |
| Q4 2020 | $94,000 | +20.5% | 12,651 | -1.0% | 0.00% | – |
| Q3 2020 | $78,000 | -29.1% | 12,785 | -3.2% | 0.00% | -100.0% |
| Q2 2020 | $110,000 | +197.3% | 13,210 | +71.3% | 0.00% | – |
| Q1 2019 | $37,000 | -24.5% | 7,710 | +0.9% | 0.00% | – |
| Q4 2018 | $49,000 | -22.2% | 7,639 | -0.8% | 0.00% | – |
| Q3 2018 | $63,000 | -18.2% | 7,697 | +4.3% | 0.00% | – |
| Q2 2018 | $77,000 | – | 7,381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 2,433,230 | $18,128,000 | 8.76% |
| Solas Capital Management, LLC | 800,000 | $5,960,000 | 4.55% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,375,000 | 0.53% |
| 683 Capital Management, LLC | 1,110,000 | $8,269,000 | 0.39% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $298,000 | 0.26% |
| Avoro Capital Advisors LLC | 1,670,000 | $12,442,000 | 0.21% |
| Eventide Asset Management | 1,120,000 | $8,344,000 | 0.13% |
| Hartford Financial Management Inc. | 38,848 | $289,000 | 0.08% |
| Granahan Investment Management | 394,810 | $2,941,000 | 0.07% |
| Planned Solutions, Inc. | 800 | $6,000 | 0.01% |